Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 8/20 | 0.51 |
| ▸ | NPC1 | O15118 | 6/20 | 0.51 |
| ▸ | CASP1 | P29466 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.50 |
| ▸ | TSHR | P16473 | 5/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.48 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.48 |
| ▸ | STAT1 | P42224 | 1/20 | 0.48 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.48 |
| ▸ | RELA | Q04206 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 4/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.48 |
| ▸ | GLA | P06280 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2906397 | 1.00 | RAB9A (0.51) | RAB9ANPC1CASP1L3MBTL1TSHR | |
| SCHEMBL994563 | 0.95 | RAB9A (0.55) | RAB9ANPC1CASP1L3MBTL1TSHR | |
| SCHEMBL3369754 | 0.93 | EPHX1 (0.54) | RAB9ANPC1CASP1L3MBTL1ALDH1A1 | |
| SCHEMBL3368234 | 0.93 | EPHX1 (0.54) | RAB9ANPC1CASP1L3MBTL1ALDH1A1 | |
| SCHEMBL2909014 | 0.92 | RAB9A (0.46) | RAB9ANPC1CASP1L3MBTL1TSHR | |
| SCHEMBL6675218 | 0.90 | TSHR (0.56) | RAB9ANPC1CASP1L3MBTL1TSHR | |
| SCHEMBL3365339 | 0.89 | SMN1; SMN2 (0.46) | RAB9ANPC1CASP1SMN1; SMN2ALDH1A1 | |
| SCHEMBL3366859 | 0.89 | SMN1; SMN2 (0.46) | RAB9ANPC1CASP1SMN1; SMN2ALDH1A1 | |
| SCHEMBL6256084 | 0.89 | RAB9A (0.52) | RAB9ANPC1CASP1L3MBTL1TSHR | |
| SCHEMBL6578691 | 0.88 | TSHR (0.51) | RAB9ANPC1CASP1L3MBTL1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1440065-B1 | METHOD FOR PREPARING ALKOXYCARBONYLAMINO-TRIAZINES | BASF SE (DE) | 2010-10-06 | — | — | EP | disclosed |
| EP-1575927-B1 | METHOD FOR THE PRODUCTION OF ALKOXYCARBONYLAMINO TRIAZINES | BASF SE (DE) | 2010-08-04 | — | — | EP | disclosed |
| US-7507818-B2 | Method for the production of alkoxycarbonylaminotriazines | BASF AKTIENGESELLSCHAFT (DE) | 2009-03-24 | — | — | US | disclosed |
| US-7371856-B2 | Preparation of alkoxycarbonylaminotriazines | BASF AKTIENGESELLSCHAFT (DE) | 2008-05-13 | — | — | US | disclosed |
| US-20070083047-A1 | Preparation of Alkoxycarbonylaminotriazines | BASF AKTIENGESELLSCHAFT (DE) | 2007-04-12 | — | — | US | disclosed |
| US-7169923-B2 | Method for preparing alkoxycarbonylamino-triazines | BASF AKTIENGESELLSCHAFT (DE) | 2007-01-30 | — | — | US | disclosed |
| US-20060069254-A1 | Method for the production of alkoxycarbonylamino triazines | BASF AKTIENGESELLSCHAFT (DE) | 2006-03-30 | — | — | US | disclosed |
| US-20040249149-A1 | Method for preparing alkoxycarbonylamino-triazines | BASF AKTIENGESELLSCHAFT (DE) | 2004-12-09 | — | — | US | disclosed |
| US-6506898-B1 | Halogen-free, purity; curing agents | CYTEC TECHNOLOGY CORP. | 2003-01-14 | — | — | US | disclosed |
| EP-0624577-B1 | Process for the preparation of 1,3,5-triazine carbamates, at least biscarbamate functional 1,3,5-triazines | CYTEC TECH CORP (US) | 2001-09-19 | — | — | EP | disclosed |
| US-6288226-B1 | CURING CARBONATES | CYTEC TECHNOLOGY CORPORATION | 2001-09-11 | — | — | US | disclosed |
| US-6063922-A | Carbamate functional 1,3,5-triazines | CYTEC TECHNOLOGY CORP. (US) | 2000-05-16 | — | — | US | disclosed |
| EP-0976739-A2 | A Process for the preparation of 1,3,5-triazine carbamates, at least biscarbimate functional 1,3,5-triazines as well as use of 1,3,5-triazine carbamates | CYTEC TECHNOLOGY CORP. (US) | 2000-02-02 | — | — | EP | disclosed |
| US-5792866-A | Process for the preparation of 1,3,5-triazine carbamates from amino 1,3,5-triazines and organic carbonates | CYTEC TECHNOLOGY CORPORATION (US) | 1998-08-11 | — | — | US | disclosed |
| US-5705641-A | Process for the preparation of 1,3,5-triazine carbamates from amino-1,3,5-triazines and organic carbonates | CYTEC TECHNOLOGY CORP. (US) | 1998-01-06 | — | — | US | disclosed |
| EP-0624577-A1 | Process for the preparation of 1,3,5-triazine carbamates, at least biscarbamate functional 1,3,5-triazines and their use as crosslinkers | CYTEC TECHNOLOGY CORP. (US) | 1994-11-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040249149-A1 | Method for preparing alkoxycarbonylamino-triazines | ADH1C, PNMT, TET2 | RAB9A 4268/4885NPC1 4123/4885CASP1 4466/4885 |
| US-20060069254-A1 | Method for the production of alkoxycarbonylamino triazines | ADH1C, ADH5, ADH1A | RAB9A 4434/4885NPC1 3027/4885CASP1 3756/4885 |
| US-20070083047-A1 | Preparation of Alkoxycarbonylaminotriazines | ADH1C, TET2, PNMT | RAB9A 3671/4885NPC1 4355/4885CASP1 4467/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.